A carregar...
Myelofibrosis: an update on drug therapy in 2016
INTRODUCTION: Primary myelofibrosis (PMF) is the least common but the most aggressive of the classic Philadelphia chromosome-negative myeloproliferative neoplasms. Survival is much shorter in PMF than in polycythemia vera (PV) or essential thrombocythemia (ET). Post-PV/ET myelofibrosis (MF) is clini...
Na minha lista:
| Publicado no: | Expert Opin Pharmacother |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669058/ https://ncbi.nlm.nih.gov/pubmed/27774820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14656566.2016.1252333 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|